课题基金 / 基金详情

项目摘要

项目成果

JOHN R ENGEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Improper or untimely activation of Src-family kinases, key signal transduction molecules, contributes to many cancers and to AIDS progression. Multiple internal regulatory elements cooperate to hold the proteins in an inactive conformation until kinase activity is required. Mutations or binding of other proteins (including HIV Nef) can displace the SH3 and/or SH2 domain(s) from regulatory positions in the inactive conformation, thereby leading to inappropriate activation and abnormal signalling. It is unclear what the conformational changes are during activation. If detailed descriptions of the changes were obtained, a more complete understanding of Src-family kinases would result, and therefore additional strategies to combat disease-related activation may follow. Hydrogen exchange (HX) mass spectrometry (MS) techniques can be used to investigate structural changes in proteins because hydrogen exchange is very sensitive to changes in protein conformation. HXMS offers the promise of working with small amounts of protein, conditions not possible with most previous biophysical analyses of Src-family kinases. To identify conformational changes in Src-family proteins during normal and vitally-induced activation, three specific aims will be accomplished: (1) Define the conformational requirements for Src-family kinase activation. Forms of Hck that model completely inactive and completely active will be separately probed with HXMS and the results compared, thereby revealing regions of Hck that undergo conformational changes during activation. (2) Determine how viral proteins alter the inactive conformation of Src-family kinases. Activation of Hck by HIV Nef and Lck by the Tip protein from Herpesvirus saimiri will be probed with HXMS. Changes in hydrogen exchange when Hck/Lck are bound versus when free are expected to reveal how and where the viral proteins induce activating conformational changes. Regions of protein:protein interaction should suggest new, alternative areas to target therapeutically. (3) Establish if various Src-famity members have unique conformational responses to HIV Nef Because all Src-family kinases are not activated by HIV Nef, HX will be compared for several family members in the presence of HIV Nef to determine how conformation contributes to the "natural resistance" of some family members towards Nef-induced activation. Taken together, these three Aims are expected to provide substantial information about the role of conformational changes in the activation of Src-family kinases, obvious targets in disease prevention.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Altered dynamics in Lck SH3 upon binding to the LBD1 domain of Herpesvirus saimiri Tip.
与疱疹病毒 saimiri Tip 的 LBD1 结构域结合后,Lck SH3 的动力学发生改变。
DOI: 10.1110/ps.052016406
发表时间: 2006
期刊: Protein science : a publication of the Protein Society
影响因子: --
作者: [Weis,DavidD, Kjellen,Peter, Sefton,BartholomewM, Engen,JohnR]
通讯作者: Engen,JohnR
High-speed and high-resolution UPLC separation at zero degrees Celsius.
零摄氏度的高速和高分辨率UPLC分离。
DOI: 10.1021/ac8008862
发表时间: 2008-09-01
期刊: ANALYTICAL CHEMISTRY
影响因子: 7.4
作者: [Wales, Thomas E., Fadgen, Keith E., Gerhardt, Geoff C., Engen, John R.]
通讯作者: Engen, John R.
Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS.
氢/氘交换MS对蛋白质构象和动力学的分析。
DOI: 10.1021/ac901154s
发表时间: 2009-10-01
期刊: ANALYTICAL CHEMISTRY
影响因子: 7.4
作者: [Engen, John R.]
通讯作者: Engen, John R.
DOI: 10.1002/0471140864.ps1706s58
发表时间: 2009-11-01
期刊: Current protocols in protein science
影响因子: --
作者: [Morgan, Christopher R, Engen, John R]
通讯作者: Engen, John R
8
    Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
    • 批准号:
      10304896
    • 项目类别:
    • 资助金额:
      $47.13万
    • 财政年份:
      2019
    • 负责人:
      JOHN R ENGEN
    • 依托单位:
    Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
    • 批准号:
      9895250
    • 项目类别:
    • 资助金额:
      $54.45万
    • 财政年份:
      2019
    • 负责人:
      JOHN R ENGEN
    • 依托单位:
    Conformational Regulation and Therapeutic Targeting of Oncogenic KRAS
    • 批准号:
      10062486
    • 项目类别:
    • 资助金额:
      $48.09万
    • 财政年份:
      2019
    • 负责人:
      JOHN R ENGEN
    • 依托单位:
    Extending the applications of hydrogen exchange mass spectrometry
    • 批准号:
      8928002
    • 项目类别:
    • 资助金额:
      $29.55万
    • 财政年份:
      2012
    • 负责人:
      JOHN R ENGEN
    • 依托单位:
    海外基金